scholarly article | Q13442814 |
P50 | author | Hunjoo Ha | Q40008914 |
Hi-Bahl Lee | Q121364870 | ||
P2093 | author name string | Yoon Jin Choi | |
Masanori Kitamura | |||
Mi Ra Yu | |||
P433 | issue | 4 | |
P921 | main subject | mesangial cell | Q3331086 |
P304 | page(s) | 894-902 | |
P577 | publication date | 2002-04-01 | |
P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
P1476 | title | Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells | |
P478 | volume | 13 |
Q37190244 | 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway |
Q28393095 | A novel transcriptional mechanism of cell type-specific regulation of vascular gene expression by glucose |
Q24563997 | Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells |
Q41894332 | Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products |
Q38758929 | Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology |
Q35766906 | Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction |
Q27323293 | Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice |
Q40790185 | Chondroitin sulfate prevents peritoneal fibrosis in mice by suppressing NF-κB activation |
Q36682692 | Combined Effects of PPAR γ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells |
Q53766666 | Consumption of polyphenol-rich Morus alba leaves extract attenuates early diabetic retinopathy: the underlying mechanism. |
Q92462286 | Correlations between serum inflammatory markers and comorbidities in patients with end-stage renal disease |
Q38981875 | Crosstalk between protective autophagy and NF-κB signal in high glucose-induced podocytes |
Q41854992 | Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. |
Q39327680 | Diabetic nephropathy: Time to withhold development and progression - A review |
Q39178804 | Effect of cilostazol in treating diabetes-associated microvascular complications |
Q27303768 | Effective Delivery of Endogenous Antioxidants Ameliorates Diabetic Nephropathy |
Q34670737 | Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy |
Q33995102 | Glycated albumin upregulates upstream stimulatory factor 2 gene transcription in mesangial cells |
Q41807679 | High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin |
Q33568917 | High glucose and diabetes enhanced store-operated Ca(2+) entry and increased expression of its signaling proteins in mesangial cells |
Q33565706 | High glucose stimulates TNFα and MCP-1 expression in rat microglia via ROS and NF-κB pathways. |
Q36213039 | Histone acetyltransferase PCAF regulates inflammatory molecules in the development of renal injury |
Q92479214 | Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy |
Q37683393 | Hydrogen sulfide suppresses oxidized low-density lipoprotein (ox-LDL)-stimulated monocyte chemoattractant protein 1 generation from macrophages via the nuclear factor κB (NF-κB) pathway |
Q37253975 | Hyperglycemia Aggravates Hepatic Ischemia Reperfusion Injury by Inducing Chronic Oxidative Stress and Inflammation. |
Q89578732 | IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target |
Q34459819 | Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury |
Q26765470 | Incretin-Based Therapy for Prevention of Diabetic Vascular Complications |
Q26866480 | Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets |
Q38255902 | Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment. |
Q36117573 | Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy |
Q64258467 | Interleukin 17A promotes diabetic kidney injury |
Q39867039 | Lipid metabolism and inflammation modulated by Vitamin D in liver of diabetic rats |
Q28543063 | Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFα related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats |
Q37167303 | NOX enzymes and diabetic complications |
Q38473579 | Oxidation as an important factor of protein damage: Implications for Maillard reaction. |
Q41912037 | Oxidative stress as a common mediator for apoptosis induced-cardiac damage in diabetic rats |
Q28082703 | Oxidative stress in obesity: a critical component in human diseases |
Q38019841 | Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies |
Q34081808 | Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives. |
Q55058976 | Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes. |
Q82270824 | Renoprotective effects of clarithromycin via reduction of urinary MCP-1 levels in type 2 diabetic patients |
Q54273203 | Role of NF-κB activation and VEGF gene polymorphisms in VEGF up regulation in non-proliferative and proliferative diabetic retinopathy. |
Q26849691 | Role of T cells in type 2 diabetic nephropathy |
Q49833771 | Short Term High Glucose Treatment Decreased Abundance of Orai1 Protein through Posttranslational Mechanisms in Rat Mesangial Cells |
Q64261600 | Sirt1-hypoxia-inducible factor-1α interaction is a key mediator of tubulointerstitial damage in the aged kidney |
Q41897138 | Small ubiquitin-like modifier 4 M55V polymorphism is not associated with diabetic nephropathy in Iranian type 2 diabetes patients |
Q39735007 | Suppressors of cytokine signaling abrogate diabetic nephropathy |
Q42968994 | Sweet debate: fructose versus glucose in diabetic kidney disease |
Q28083205 | Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy |
Q36788430 | Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease |
Q37264349 | The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability. |
Q33995115 | Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis |
Q85446483 | Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus |
Q37319731 | Vitamin D and diabetic nephropathy |
Q58760376 | lectin alleviates diabetic nephropathy by inhibiting the LOX1/NF-κB/caspase-9 signaling pathway |
Search more.